Yahoo
HKSE - Delayed Quote HKD

MedSci Healthcare Holdings Limited (2415.HK)

0.815 0.000 (0.00%)
At close: November 5 at 3:46:39 PM GMT+8
Chart Range Bar
Loading chart for 2415.HK
  • Previous Close 0.815
  • Open 0.720
  • Bid 0.725 x --
  • Ask 0.815 x --
  • Day's Range 0.720 - 0.815
  • 52 Week Range 0.500 - 1.470
  • Volume 168,500
  • Avg. Volume 177,158
  • Market Cap (intraday) 446.226M
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) 27.17
  • EPS (TTM) 0.030
  • Earnings Date --
  • Forward Dividend & Yield 0.02 (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

MedSci Healthcare Holdings Limited, an investment holding company, operates as a physician platform solutions in the People's Republic of China and the United States. The company offers precision omni-channel marketing solutions, including precision detailing, medical content creation, and online survey services; physician platform solutions, such as medical knowledge and clinical study assistance services; data and artificial intelligence solutions; and real-world study solutions comprising designing, administration, and execution of digital real-world evidence-based research. It primarily serves pharmaceutical and medical device companies, as well as hospitals and doctors. MedSci Healthcare Holdings Limited was founded in 2012 and is headquartered in Shanghai, the People's Republic of China.

www.medscihealthcare.com

396

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2415.HK
34.80%
HANG SENG INDEX (^HSI)
4.48%

1-Year Return

2415.HK
43.79%
HANG SENG INDEX (^HSI)
7.57%

3-Year Return

2415.HK
79.98%
HANG SENG INDEX (^HSI)
36.26%

5-Year Return

2415.HK
90.79%
HANG SENG INDEX (^HSI)
1.56%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.84%

  • Return on Assets (ttm)

    0.69%

  • Return on Equity (ttm)

    1.31%

  • Revenue (ttm)

    262.58M

  • Net Income Avi to Common (ttm)

    15.34M

  • Diluted EPS (ttm)

    0.030

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.21B

  • Total Debt/Equity (mrq)

    0.47%

  • Levered Free Cash Flow (ttm)

    18.55M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: